GGiantBullStocks

Pacira BioSciences, Inc. (PCRX)

NASDAQ · Healthcare

$25.35-1.02%

As of Jul 20, 2026

Price history

Key statistics

Market cap
$1.01B
P/E ratio
EPS
Volume
475,832
52-week high
52-week low
Open
$25.50
Day high
$26.12
Day low
$25.22

Financial highlights

Fiscal yearRevenueNet incomeEPS
2025$726.41M$7.03M$0.16
2024$700.97M-$99.56M-$2.15
2023$674.98M$41.96M$0.89
2022$666.82M$15.91M$0.34
2021$541.53M$41.98M$0.92

About Pacira BioSciences, Inc.

Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers the iovera system, a non-opioid, handheld cryoanalgesia device capable of delivering precisely controlled cold temperatures to targeted nerves. Pacira also develops its unique multivesicular liposome (MVL) drug delivery technology, which encapsulates therapeutic compounds while preserving their inherent molecular structure. Established in 2006, the firm was formerly known as Pacira Pharmaceuticals, Inc. until its name change to Pacira BioSciences, Inc. in April 2019. Its main corporate office is situated in Tampa, Florida.

CEO
Frank D. Lee
Employees
825
Country
US
IPO date
Feb 3, 2011

Similar stocks

Other Healthcare companies

Frequently asked questions

What is Pacira BioSciences, Inc.'s stock price today?
PCRX is trading at $25.35 as of Jul 20, 2026.
What is Pacira BioSciences, Inc.'s market cap?
Pacira BioSciences, Inc. (PCRX) has a market capitalization of $1.01B.
Does Pacira BioSciences, Inc. pay a dividend?
Pacira BioSciences, Inc. did not pay a dividend in its most recent reported fiscal year.
What sector is Pacira BioSciences, Inc. in?
Pacira BioSciences, Inc. operates in the Healthcare sector.